User:Mr. Ibrahem/Bexagliflozin

Bexagliflozin, sold under the brand name Brenzavvy among others, is a medication used to treat type 2 diabetes. It is used with diet and exercise. It is taken by mouth.

Common side effects include vaginal yeast infections, urinary tract infections, and increased urination. Serious side effects may include diabetic ketoacidosis, limb amputation, low blood sugar, Fournier’s gangrene, and kidney problems. Use is not recommended during the latter part of pregnancy. It is a sodium-glucose cotransporter 2 (SGLT2) inhibitor.

Bexagliflozin was approved for medical use in the United States in 2023. The cost in the United States was not clear as of early 2023.